Exploring the timeline and network interplay of immune mediators in COVID-19 patients according to disease outcome

20260 citationsJournal Articlegold Open Access

Authors

Gabriel Macedo Costa Guimarães · Universidade Federal Fluminense

Christiane Costa-Pereira · Fundação Oswaldo Cruz

Renan Faustino · Universidade Federal Fluminense

Lilian Santos Alves · Universidade Federal Fluminense

Fabiana Rabe Carvalho · Universidade Federal Fluminense

Thalia Costa Medeiros · Universidade Federal Fluminense

Joaquim Pedro Brito-de-Sousa

Abstract

Overall, these findings support clinical applicability of measuring serum immune mediators as complementary prognostic biomarkers for early classification and prediction of disease outcome in COVID-19 patients.

Topics & Keywords

COVID-19 Clinical Research Studies SARS-CoV-2 and COVID-19 Research Long-Term Effects of COVID-19

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Frontiers in Immunology

Volume 17, pp. 1765997-1765997

DOI: 10.3389/fimmu.2026.1765997

Field-Weighted Citation Impact: 0.00